I'm not sure I'd dismiss that appointment so lightly......Immutep already has
the pre-eminent research laboratory into the lag-3 gene, why introduce a
HIV focused research scientist onto the scene at this stage unless there
was some thought of combining "efti" with existing HIV treatments?
New Appointment...Mathieu Angin, page-6
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.8¢ |
Change
-0.023(6.82%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $1.351M | 4.354M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 196862 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 116640 | 24 |
View Market Depth
| Last trade - 14.38pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
